ReviewNPJ breast cancer2024

Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.

Kelly E McCann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.